Literature DB >> 17471173

Cryptotanshinone inhibits chemotactic migration in macrophages through negative regulation of the PI3K signaling pathway.

M-J Don1, J-F Liao, L-Y Lin, W-F Chiou.   

Abstract

BACKGROUND AND
PURPOSE: Cryptotanshinone, the major tanshinone isolated from Salvia miltiorrhiza Bunge, exhibits anti-inflammatory activity. However, there is no report on the effect of cryptotanshinone on recruitment of leukocytes to inflammatory sites. We therefore assessed the effects of cryptotanshinone on macrophage chemotaxis. EXPERIMENTAL APPROACH: Macrophage migration induced by complement 5a (C5a) or macrophage inflammatory protein-1alpha (MIP-1alpha) was measured in vitro. Intracellular kinase translocation and phosphorylation was assessed by Western blotting. KEY
RESULTS: RAW264.7 cell migration towards C5a (1 microg ml(-1)) was significantly inhibited by cryptotanshinone (1, 3, 10 and 30 microM) in a concentration-dependent manner. Primary human macrophages stimulated by C5a were similarly inhibited. C5a-evoked migration in RAW264.7 cells was significantly suppressed by wortmannin (phosphatidylinositol 3-kinase (PI3K) inhibitor), PD98059 (MEK1/2 inhibitor) and SB203580 (p38 mitogen-activated protein kinase (MAPK) inhibitor), but not by SP600125 (c-Jun N-terminal kinase (JNK) inhibitor), suggesting that activation of PI3K, ERK1/2 and p38 MAPK signal pathways was involved in responses to C5a. Western blotting revealed that cryptotanshinone significantly inhibited PI3K-p110gamma membrane translocation and phosphorylation of Akt (PI3K downstream effector protein) and ERK1/2 induced by C5a. However, neither p38 MAPK nor JNK phosphorylation was affected by cryptotanshinone. Wortmannin significantly attenuated C5a-induced PI3K-p110gamma translocation, Akt and ERK1/2 phosphorylation. PD98059 suppressed ERK1/2 phosphorylation but failed to modify PI3K-p110gamma translocation by C5a stimulation. Furthermore, MIP-1alpha-induced cell migration and PI3K-p110gamma translocation were also inhibited by cryptotanshinone in a concentration-dependent manner. CONCLUSIONS AND IMPLICATIONS: Inhibition of macrophage migration by cryptotanshinone involved inhibition of PI3K activation with consequent reduction of phosphorylation of Akt and ERK1/2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17471173      PMCID: PMC2013997          DOI: 10.1038/sj.bjp.0707271

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

Review 1.  New insights into the control of MAP kinase pathways.

Authors:  J English; G Pearson; J Wilsbacher; J Swantek; M Karandikar; S Xu; M H Cobb
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

2.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.

Authors:  T Sasaki; J Irie-Sasaki; R G Jones; A J Oliveira-dos-Santos; W L Stanford; B Bolon; A Wakeham; A Itie; D Bouchard; I Kozieradzki; N Joza; T W Mak; P S Ohashi; A Suzuki; J M Penninger
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

3.  Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation.

Authors:  J A Nick; S K Young; K K Brown; N J Avdi; P G Arndt; B T Suratt; M S Janes; P M Henson; G S Worthen
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

Review 4.  Signalling through Class I PI3Ks in mammalian cells.

Authors:  P T Hawkins; K E Anderson; K Davidson; L R Stephens
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

5.  Diterpenoids from Salvia miltiorrhiza.

Authors:  H C Lin; W L Chang
Journal:  Phytochemistry       Date:  2000-04       Impact factor: 4.072

6.  Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway.

Authors:  J M Ayala; S Goyal; N J Liverton; D A Claremon; S J O'Keefe; W A Hanlon
Journal:  J Leukoc Biol       Date:  2000-06       Impact factor: 4.962

7.  Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza Bunge.

Authors:  D S Lee; S H Lee; J G Noh; S D Hong
Journal:  Biosci Biotechnol Biochem       Date:  1999-12       Impact factor: 2.043

8.  Stimulation of human neutrophils by chemotactic factors is associated with the activation of phosphatidylinositol 3-kinase gamma.

Authors:  P H Naccache; S Levasseur; G Lachance; S Chakravarti; S G Bourgoin; S R McColl
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

9.  Chemoattractant receptors activate distinct pathways for chemotaxis and secretion. Role of G-protein usage.

Authors:  B Haribabu; D V Zhelev; B C Pridgen; R M Richardson; H Ali; R Snyderman
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

Authors:  E Hirsch; V L Katanaev; C Garlanda; O Azzolino; L Pirola; L Silengo; S Sozzani; A Mantovani; F Altruda; M P Wymann
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

View more
  17 in total

1.  Cryptotanshinone inhibits cancer cell proliferation by suppressing Mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation.

Authors:  Wenxing Chen; Yan Luo; Lei Liu; Hongyu Zhou; Baoshan Xu; Xiuzhen Han; Tao Shen; Zhijun Liu; Yin Lu; Shile Huang
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

Review 2.  Molecular evidence of cryptotanshinone for treatment and prevention of human cancer.

Authors:  Wenxing Chen; Yin Lu; Guangying Chen; Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

3.  Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E.

Authors:  Yuqing Ge; Rubin Cheng; Yuhong Zhou; Jianping Shen; Laijun Peng; Xiaofeng Xu; Qun Dai; Pei Liu; Haibing Wang; Xiaoqiong Ma; Jia Jia; Zhe Chen
Journal:  Mol Cell Biochem       Date:  2012-05-22       Impact factor: 3.396

4.  Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling.

Authors:  Liang Lu; Cuixian Li; Dong Li; Ying Wang; Chun Zhou; Weiwei Shao; Jin Peng; Yan You; Xinwen Zhang; Xiaoyan Shen
Journal:  Mol Cell Biochem       Date:  2013-06-06       Impact factor: 3.396

5.  Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells.

Authors:  Wenxing Chen; Lei Liu; Yan Luo; Yoshinobu Odaka; Sanket Awate; Hongyu Zhou; Tao Shen; Shizhong Zheng; Yin Lu; Shile Huang
Journal:  Cancer Prev Res (Phila)       Date:  2012-04-03

6.  Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1).

Authors:  Zhiping Liu; Suowen Xu; Xiaoyang Huang; Jiaojiao Wang; Si Gao; Hong Li; Changhua Zhou; Jiantao Ye; Shaorui Chen; Zheng-Gen Jin; Peiqing Liu
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

7.  Oral Administration of Cryptotanshinone-Encapsulated Nanoparticles for the Amelioration of Ulcerative Colitis.

Authors:  Li Zhang; Longfei Yu; Yueguang Wei
Journal:  Cell Mol Bioeng       Date:  2021-10-26       Impact factor: 2.321

8.  Quercetin suppresses MIP-1α-induced adipose inflammation by downregulating its receptors CCR1/CCR5 and inhibiting inflammatory signaling.

Authors:  Hye-Ji Noh; Chu-Sook Kim; Ji-Hye Kang; Jun-Young Park; Suck-Young Choe; Soon-Myoung Hong; Hoon Yoo; Taesun Park; Rina Yu
Journal:  J Med Food       Date:  2013-12-10       Impact factor: 2.786

9.  8-Prenylkaempferol Suppresses Influenza A Virus-Induced RANTES Production in A549 Cells via Blocking PI3K-Mediated Transcriptional Activation of NF-κB and IRF3.

Authors:  Wen-Fei Chiou; Chen-Chih Chen; Bai-Luh Wei
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

10.  Evodia rutaecarpa and Three Major Alkaloids Abrogate Influenza A Virus (H1N1)-Induced Chemokines Production and Cell Migration.

Authors:  Wen-Fei Chiou; Han-Chieh Ko; Bai-Luh Wei
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.